Newer systemic antifungal drugs for the treatment of onychomycosis
MM Chiritescu, MES Chiritescu, RK Scher - Clinics in podiatric medicine …, 1996 - Elsevier
Onychomycosis is a fungal disease of the nail caused by dermatophytes, yeasts, and
moulds; it is often considered incorrectly synonymous with tinea unguium, which is defined …
moulds; it is often considered incorrectly synonymous with tinea unguium, which is defined …
Antifungal combination treatment: a future perspective
C Fohrer, L Fornecker, Y Nivoix, C Cornila… - International journal of …, 2006 - Elsevier
The use of antifungal combination therapy is a new clinical approach for combating fungal
infections. Although few conclusive clinical studies have been performed to date, data exist …
infections. Although few conclusive clinical studies have been performed to date, data exist …
The future of antifungal therapy
JR Graybill - Clinical Infectious Diseases, 1996 - academic.oup.com
In the late 1970s the options for systemic antifungal therapy doubled with the addition of
intravenous miconazole and oral ketoconazole to the two previously available agents …
intravenous miconazole and oral ketoconazole to the two previously available agents …
Antifungal combinations
The increase in fungal infections and the change in fungal epidemiology is caused by the
extensive use of antifungal agents to treat fungal infections that are being diagnosed in …
extensive use of antifungal agents to treat fungal infections that are being diagnosed in …
Onychomycosis: classification and diagnosis.
AK Gupta, JE Ryder, RC Summerbell - Journal of drugs in …, 2004 - europepmc.org
Onychomycosis is a common infection of the nail predominantly caused by anthropophilic
dermatophytes, and to a lesser extent by yeasts (Candida species) and non-dermatophyte …
dermatophytes, and to a lesser extent by yeasts (Candida species) and non-dermatophyte …
The future of onychomycosis therapy may involve a combination of approaches
RJ Hay - British Journal of Dermatology, 2001 - academic.oup.com
Onychomycosis is a fungal infection of the nail unit, most commonly caused by the
anthropophilic dermatophyte fungi. It is generally accepted that this disease is increasing in …
anthropophilic dermatophyte fungi. It is generally accepted that this disease is increasing in …
Antifungal therapy: potential interactions with other classes of drugs
DR Bickers - Journal of the American Academy of Dermatology, 1994 - Elsevier
Combination drug therapy is widely used for the management of many common medical
conditions. The concurrent use of more than one drug can significantly alter the therapeutic …
conditions. The concurrent use of more than one drug can significantly alter the therapeutic …
Antifungal drugs: what brings the future?
R Van Daele, I Spriet, J Wauters, J Maertens… - Medical …, 2019 - academic.oup.com
The high burden and growing prevalence of invasive fungal infections (IFIs), the toxicity and
interactions associated with current antifungal drugs, as well as the increasing resistance …
interactions associated with current antifungal drugs, as well as the increasing resistance …
Treatment failures and relapses in onychomycosis: a stubborn clinical problem
JE Arrese, GE Piérard - Dermatology, 2003 - karger.com
The therapeutic outcome of onychomycoses is uncertain. Comparative short-term efficacy
studies on antifungals abound and report contradictory findings. Few unbiased follow-up …
studies on antifungals abound and report contradictory findings. Few unbiased follow-up …
[图书][B] Ketoconazole in the management of fungal disease.
HB Levine - 1982 - cabidigitallibrary.org
The first section of this handbook, on Mycoses and Antimycotics, includes contributions by:
Hay, RJ Superficial and deep mycoses: the extent of the problem (The mycoses are …
Hay, RJ Superficial and deep mycoses: the extent of the problem (The mycoses are …